| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca6f960daf9bee2b8db00fc81658b543 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 |
| filingDate |
2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d0fc5b3d2a3bce96e43c2c2801a03ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd8427db3029a0d90f0c98d4a91ddf8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c4760ad6e1d48cb70bae7120df9ba08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e66b8b8b7b428ca7c84f3893fa0b3dc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c962daa15730be0dc61a72a2dfe6a87b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92af1e034f98d041486874be3a2732bb |
| publicationDate |
2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2310051-A1 |
| titleOfInvention |
Combination of a parp inhibitor and an akt kinase activating compound |
| abstract |
The primary subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination in the treatment of pathological conditions related to PARP activation and/or that could benefit from Akt activation. A further subject of the invention is the use of a PARP inhibitor and an Akt kinase activating compound in combination for the preparation of pharmaceutical composition or kit for the treatment of a pathological condition related to PARP activation. The invention also relates to pharmaceutical composition, which contains a PARP-inhibitor and an Akt kinase activating compound together with auxiliaries generally used in pharmacy. |
| priorityDate |
2008-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |